Health Sciences



In the News


The New York Times

Managing ADHD is hard. These coaches want to help

Lisa Joy Tutttle of the Perelman School of Medicine spoke about Penn’s Adult A.D.H.D. Treatment and Research Program, which provides clients with coaching and other support. “We’re really trying to help people develop their own insights and solutions,” she said.

FULL STORY →



Philadelphia Business Journal

Cell therapy pioneer Dr. Carl June to chair Chinese biotech firm's scientific advisory board

Carl June of the Perelman School of Medicine has agreed to serve as chairman of Bioheng Biotech Co.’s scientific advisory board. "Bioheng has made impressive progress in both universal CAR-T and enhanced CAR-T [therapies] for solid tumor, and achieved outstanding clinical results," June said. "I look forward to a faster clinical application and sooner benefit to cancer patients."

FULL STORY →



US News

Mandates, not recommendations, work best to get folks vaccinated: Study

PIK Professor Dolores Albarracín authored a study that found mandates are more likely to lead to vaccine uptake than suggestions. “The requirement condition works better across the board, for different racial and ethnic groups and even among people who dislike feeling and being controlled by others,” she said.

FULL STORY →



The New York Times

Waiting on U.S. mandate, some nursing homes are slow to vaccinate staff

PIK Professor Ezekiel Emanuel said lower COVID-19 vaccination rates lead to more infections. “We should be clear that mandates have been working and have been working in every industry that has tried them,” he said.

FULL STORY →



Scientific American

Four success stories in gene therapy

Jean Bennett and Albert Maguire of the Perelman School of Medicine developed a gene therapy to treat blindness in patients with retinal dystrophy caused by mutations in the RPE65 gene. “These people can now do things they never could have dreamed of doing, and they’re more independent and enjoying life,” said Bennett.

FULL STORY →